LPAR1 Antikörper (N-Term)
Kurzübersicht für LPAR1 Antikörper (N-Term) (ABIN358617)
Target
Alle LPAR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 28-58, N-Term
-
Spezifität
- This antibody reacts to EDG2.
-
Aufreinigung
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
-
Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between aa 28-58 from the N-terminal region of human EDG2.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
-
- LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))
-
Andere Bezeichnung
- EDG-2 / LPAR1
-
Hintergrund
- The EDG2 integral membrane protein is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion.Synonyms: EDG2, LPA receptor 1, LPA-1, LPA1, LPAR1, Lysophosphatidic acid receptor 1, Lysophosphatidic acid receptor Edg-2
-
Gen-ID
- 1902, 9606
-
UniProt
- Q92633
-
Pathways
- Myometrial Relaxation and Contraction, Smooth Muscle Cell Migration
Target
-